Drawing for COSTELLO MEDICAL

USPTO serial 79460712

COSTELLO MEDICAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with COSTELLO MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable electronic publications in the field of medical and scientific data; downloadable electronic reports in relation to medical and scientific data.ACTIVE—
042Design and development of software for use in the fields of medical communication, research and scientific support and consultancy; software as a services (SaaS) featuring software for use in the fields of medical communication, research and scientific support and consultancy; software as a service (SaaS) featuring software for literature reviews, storage and retrieval of data in the medical field; software as a service (SaaS) for conducting systematic literature reviews in the pharmaceutical and medical sectors; providing online non-downloadable software for the review, screening, ranking and analysis of published scientific articles, abstracts and research publications; providing online non-downloadable artificial intelligence software for the review and analysis of scientific and medical literature; providing online non-downloadable software for use in evidence synthesis, health technology assessment and clinical guideline development; providing online non-downloadable software for the retrieval, categorisation, extraction and management of data from scientific and medical publications; providing online non-downloadable software enabling integration with third-party scientific database and content licensing platforms; providing online non-downloadable software for the generation of reports and summaries derived from systematic literature reviews; providing online non-downloadable software for the collaborative annotation and review of scientific and medical literature; providing online non-downloadable software for tracking, auditing and recording human oversight of AI-assisted literature review processes; providing online non-downloadable software incorporating natural language processing for the analysis of scientific and medical text; providing online non-downloadable machine learning software for the screening and classification of scientific and medical publications; providing online non-downloadable software for managing access controls, tiered user permissions and licensing in literature review workflows; providing online non-downloadable software for sharing and presenting systematic literature review outputs to users; software as a service (SaaS) enabling closed-environment AI-assisted review of scientific and medical literature whereby uploaded content and associated prompts are not used to train AI models; platform as a service (PaaS) for systematic literature review in the pharmaceutical and medical sectors; application programming interface services for integration with third-party scientific content databases and publication platforms; cloud computing services relating to systematic literature review software for the pharmaceutical and medical sectors; data analytics services relating to systematic literature review and evidence synthesis in the pharmaceutical and medical sectors; technical support services relating to software for systematic literature review; research and development services relating to software for systematic literature review and AI-assisted analysis of scientific and medical literature; providing temporary use of online non-downloadable software for use by pharmaceutical, medical, academic and healthcare organisations in relation to data and literature reviews.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 15, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance